Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortizatization of Intangibles (2020 - 2023)

Historic Amortizatization of Intangibles for Biodesix (BDSX) over the last 3 years, with Q4 2023 value amounting to $328000.0.

  • Biodesix's Amortizatization of Intangibles fell 5614.97% to $328000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.2 million, marking a year-over-year decrease of 302.63%. This contributed to the annual value of $2.2 million for FY2023, which is 302.63% down from last year.
  • Per Biodesix's latest filing, its Amortizatization of Intangibles stood at $328000.0 for Q4 2023, which was down 5614.97% from $457000.0 recorded in Q3 2023.
  • In the past 5 years, Biodesix's Amortizatization of Intangibles ranged from a high of $1.9 million in Q2 2020 and a low of $280000.0 during Q1 2022
  • In the last 3 years, Biodesix's Amortizatization of Intangibles had a median value of $677000.0 in 2020 and averaged $801363.6.
  • Examining YoY changes over the last 5 years, Biodesix's Amortizatization of Intangibles showed a top increase of 17142.86% in 2023 and a maximum decrease of 5614.97% in 2023.
  • Biodesix's Amortizatization of Intangibles (Quarter) stood at $1.8 million in 2020, then tumbled by 57.93% to $748000.0 in 2022, then tumbled by 56.15% to $328000.0 in 2023.
  • Its Amortizatization of Intangibles was $328000.0 in Q4 2023, compared to $457000.0 in Q3 2023 and $634000.0 in Q2 2023.